Shares in Convatec (CTEC) rallied 8% to 244.5p after the medical devices maker upgraded its medium-term organic growth target to a range of 6% to 8% from 2027. This represented a healthy upgrade from previous guidance of 5% to 7%. Share price: 244.5p (+8%) PE: 21.5x Market cap: £6bn Yield: 2.5% Convatec believes growth is … Continue reading Convatec rallies on upgraded growth targets